Transplant Diagnostics Market By Product & Service (Instruments and Reagents & Consumables), By Screening Type (Pre-Transplant and Post-Transplant), By End User (Kidney, Liver, Heart, Lung, and Pancreas), Regional Outlook– Global Forecast up to 2030

Transplant Diagnostics Market By Product & Service (Instruments and Reagents & Consumables), By Screening Type (Pre-Transplant and Post-Transplant), By End User (Kidney, Liver, Heart, Lung, and Pancreas), Regional Outlook– Global Forecast up to 2030


We use the most thorough and iterative research technique available, with a primary focus on offering the most precise market projections and research data content to help you develop previously unheard-of levels of business acumen. The company's primary methods for qualitative market assessments and market segmentation are top-down and bottom-up techniques. We take pride in our ability to use data triangulation to examine the market from three key angles: primary data mining, a specific statistical model and framework, and primary source data validation.

We carefully choose our original raw market data for analysis from a vast collection of data that has been compiled in our repository, as well as from sets of trustworthy and validated websites, analyst evaluations, news announcements, whitepapers, and reputable paid databases. Trade journals and in-depth surveys are used to collaborate on technical data and trends. Verified sources are used to assess pricing trends and market dynamics.

We use particular data simulation models to get our market estimates and forecasts. These models are developed and tailored to match the unique needs of every study. They are nimble and adaptable. For the most part, we use a joint combination of technological analysis, economic tools, domain experience, and economic techniques to forecast and estimate the market. In general, we favor using a bottom-up method to assess the worldwide market and calculate the anticipated rate of growth.

To verify our hypotheses and the results we have gotten, we carry out in-depth primary interviews, which include phone conversations, in-person discussions, and targeted group discussions. Extensive primary research has been conducted to verify our figures and forecast. These interviews also provide us with an objective view of the market, important information on companies operating in various markets, and up-to-date business scenarios.

Transplant Diagnostics Market based on Product & Service:
  • Instruments
  • Reagents & Consumables
Transplant Diagnostics Market based on Screening Type:
  • Pre-Transplant
  • Post-Transplant
Transplant Diagnostics Market based on Organ Type:
  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
Transplant Diagnostics Market based on Geography:
  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Based on the product and service, the transplant diagnostics market is divided into divisions for instruments, reagents, and consumables. In 2021, the global market was dominated by the reagents and consumables segment. The main characteristic of this market is the higher rate of consumption of these items across all applications and end-uses, as well as higher replacement rates despite lower costs. Purchase agreements for consumables and reagents are among the tactics used by producers of these kinds of diagnostic devices. Furthermore, the primary element expediting the acceptance of reagents and consumables is their recurring acquisition.

The rapid modernization and automation of diagnostic laboratories, the rise in the number of organ transplant procedures, and the outsourcing of research and development activities by pharmaceutical and biotechnology companies to independent reference laboratories are additional factors contributing to this segment's large share.

Pre- and post-transplant screening are included in the market segmentation for transplant diagnostics based on the type of screening. Pre-transplant revenue accounted for roughly 60–64 percent of the transplant diagnostics market in 2021, giving it the lion's share of the market. Pre-transplantation analysis techniques like these are used to make sure things run smoothly and safely. The adoption of technologically improved instruments at a rapid pace and rising physician awareness are two factors that are anticipated to propel growth in the upcoming years. Additionally, a growing elderly population that is more vulnerable to many chronic illnesses as a result of weakened immunity is one of the main causes driving the pre-transplant diagnostics market expansion for diagnostic applications.

Organ types that are included in the market segmentation of transplant diagnostics include kidney, liver, heart, lung, and pancreas. In 2021, the kidney segment accounted for the largest proportion of market revenue. The market is expected to increase in segments due to the rising number of kidney transplant surgeries and the government rules that encourage organ donations in key healthcare markets. The market for serological transplant diagnostics is seeing an increase in the use of kidney and liver transplants due to the growing prevalence of renal and liver failure among the elderly population. in particular in people who have long-term illnesses. According to publications titled Chronic Kidney Disease in India released by the American Society of Nephrology, the prevalence of CKD in India varies from 1% to 13%.
  • This report illustrates the most vital attributes of the Transplant Diagnostics Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Transplant Diagnostics Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Transplant Diagnostics Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Transplant Diagnostics Market.


1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product & Service: Market Size & Analysis
5.1. Overview
5.2. Instruments
5.3. Reagents & Consumables
6. Screening Type: Market Size & Analysis
6.1. Overview
6.2. Pre-Transplant
6.3. Post-Transplant
7. Organ Type: Market Size & Analysis
7.1. Overview
7.2. Kidney
7.3. Liver
7.4. Heart
7.5. Lung
7.6. Pancreas
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. HOLOGIC, INC. (U.S.)
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. BIOFORTUNA LIMITED (U.K.)
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. TAKARA BIO INC. (JAPAN)
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. ABBOTT (U.S.)
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. DIAGNÓSTICA LONGWOOD SL (SPAIN)
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. ADAPTIVE BIOTECHNOLOGIES (U.S.)
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. NANOSTRING TECHNOLOGIES, INC.(U.S.)
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. ARQUER DIAGNOSTICS LTD (U.K.)
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. F. ALTONA DIAGNOSTICS GMBH (GERMANY)
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. ELITECHGROUP (FRANCE)
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings